Hynisz Epersone Hydrochloride Tablets

Adult dose

Epersone hydrochloride is administered orally as 50 mg 3 times a day after meals. The dosage may be adjusted appropriately according to age and symptoms.

This medication should not be administered to certain patients. For instance, individuals allergic to this drug or those with myasthenia gravis should not use it. Additionally, patients with lactose intolerance, hereditary lactose digestion enzyme deficiency, and glucose-galactose malabsorption should not take this medication. Caution is also required for those allergic to soybean oil, soybeans, or peanuts. When using this medication, it should be administered cautiously to patients with a history of hypersensitivity to drugs, patients with poor liver function, and those with lipid metabolism issues such as hyperlipoproteinemia, diabetic dyslipidemia, or pancreatitis. During the course of taking this medication, rare shock symptoms may occur, so symptoms should be closely monitored, and regular checks are necessary as there may be abnormalities in liver or kidney function. Various side effects such as anemia, skin rash, itching, insomnia, drowsiness, headache, dyspepsia, urinary retention, etc., can occur, and if any abnormal symptoms appear, immediate consultation with medical personnel is required. Particularly, if symptoms such as toxic epidermal necrolysis syndrome, which is a serious skin adverse reaction, occur, stop taking the medication immediately and seek appropriate treatment. Taking this medication may cause drowsiness, weakness, and decreased concentration, so it's advisable to avoid driving or operating hazardous machinery. Patients with lipid metabolism issues should regularly check their blood lipid levels and adjust the medication dosage accordingly. Caution is also needed when taking this drug in conjunction with similar medications due to the potential for neurological symptoms. Women who are pregnant or may become pregnant should use this medication only if the benefits of treatment outweigh the risks, and those who are breastfeeding should ideally avoid taking it or discontinue breastfeeding. Safety in pediatric patients has not been adequately established, so careful use is required, and elderly patients may need special caution due to decreased bodily function, including dosage adjustments.

Serious side effects

Shock (anaphylactic reaction), liver abnormalities (elevated ALT, AST, ALP), kidney abnormalities (proteinuria, elevated BUN), anemia, angioedema, toxic epidermal necrolysis and mucocutaneous eye syndrome (Stevens-Johnson syndrome)

Mild side effects

• Rash
• itching
• insomnia
• drowsiness
• headache
• limb paralysis
• stiffness of the body
• limb tremors
• nausea
• vomiting

This medication should be stored in a tightly sealed container to prevent air from entering and kept at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness for a longer period.

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 1000 tablets/bottle